Review





Similar Products

95
Fujirebio Inc pan apoe
Validation of the ApoE4 and <t>Pan‐ApoE</t> electrophoresis‐based capillary Western blot. (A, B) Western blots of serum (1:400 dilution) and cerebrospinal fluid (CSF) (diluted to 25 mg/L total protein concentration) probed with the anti‐Pan‐ApoE antibody (A) and anti‐ApoE4 antibody (B) from patients with APOE genotypes ε4 / ε4 , ε3 / ε4 , ε2 / ε4 , ε3 / ε3 , ε2 / ε3 , and ε2 / ε2 (each n = 1). For the APOE ε2 / ε2 genotype only serum was available. Bands at 40 kDa in both serum and CSF are observed for every ApoE isoform with the Pan‐ApoE antibody, whereas the anti‐ApoE4 antibody detects 40 kDa bands in both matrices solely in APOE ε4 genotypes. (C) Representative electropherogram illustrating chemiluminescence signal intensity as a function of molecular weight for CSF ( APOE ε3 / ε4 , diluted to 25 mg/L) and serum ( APOE ε3 / ε4 , 1:400 dilution) samples detected with anti‐Pan‐ApoE and anti‐ApoE4 antibodies. (D) Linearity of the Western blot signal (peak area) increase in CSF was assessed using CSF samples from patients with APOE ε3 / ε4 and APOE ε4 / ε4 genotypes in serial dilutions. (E) Linearity of the peak area increase in serum was evaluated by testing a serum sample from a patient with an APOE ε3 / ε4 genotype in serial dilutions.
Pan Apoe, supplied by Fujirebio Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apoe-/Lumipulse+G+ApoE4/pmc13746799-95-30-39
Average 95 stars, based on 1 article reviews
pan apoe - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
Fujirebio Inc lumipulse pan apoe
Validation of the ApoE4 and <t>Pan‐ApoE</t> electrophoresis‐based capillary Western blot. (A, B) Western blots of serum (1:400 dilution) and cerebrospinal fluid (CSF) (diluted to 25 mg/L total protein concentration) probed with the anti‐Pan‐ApoE antibody (A) and anti‐ApoE4 antibody (B) from patients with APOE genotypes ε4 / ε4 , ε3 / ε4 , ε2 / ε4 , ε3 / ε3 , ε2 / ε3 , and ε2 / ε2 (each n = 1). For the APOE ε2 / ε2 genotype only serum was available. Bands at 40 kDa in both serum and CSF are observed for every ApoE isoform with the Pan‐ApoE antibody, whereas the anti‐ApoE4 antibody detects 40 kDa bands in both matrices solely in APOE ε4 genotypes. (C) Representative electropherogram illustrating chemiluminescence signal intensity as a function of molecular weight for CSF ( APOE ε3 / ε4 , diluted to 25 mg/L) and serum ( APOE ε3 / ε4 , 1:400 dilution) samples detected with anti‐Pan‐ApoE and anti‐ApoE4 antibodies. (D) Linearity of the Western blot signal (peak area) increase in CSF was assessed using CSF samples from patients with APOE ε3 / ε4 and APOE ε4 / ε4 genotypes in serial dilutions. (E) Linearity of the peak area increase in serum was evaluated by testing a serum sample from a patient with an APOE ε3 / ε4 genotype in serial dilutions.
Lumipulse Pan Apoe, supplied by Fujirebio Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apoe-/Lumipulse+G+Pan-ApoE/pmc13746799-228-21-21
Average 94 stars, based on 1 article reviews
lumipulse pan apoe - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

99
Nikon 100x 1 49na sr apo tirf oil objective
Validation of the ApoE4 and <t>Pan‐ApoE</t> electrophoresis‐based capillary Western blot. (A, B) Western blots of serum (1:400 dilution) and cerebrospinal fluid (CSF) (diluted to 25 mg/L total protein concentration) probed with the anti‐Pan‐ApoE antibody (A) and anti‐ApoE4 antibody (B) from patients with APOE genotypes ε4 / ε4 , ε3 / ε4 , ε2 / ε4 , ε3 / ε3 , ε2 / ε3 , and ε2 / ε2 (each n = 1). For the APOE ε2 / ε2 genotype only serum was available. Bands at 40 kDa in both serum and CSF are observed for every ApoE isoform with the Pan‐ApoE antibody, whereas the anti‐ApoE4 antibody detects 40 kDa bands in both matrices solely in APOE ε4 genotypes. (C) Representative electropherogram illustrating chemiluminescence signal intensity as a function of molecular weight for CSF ( APOE ε3 / ε4 , diluted to 25 mg/L) and serum ( APOE ε3 / ε4 , 1:400 dilution) samples detected with anti‐Pan‐ApoE and anti‐ApoE4 antibodies. (D) Linearity of the Western blot signal (peak area) increase in CSF was assessed using CSF samples from patients with APOE ε3 / ε4 and APOE ε4 / ε4 genotypes in serial dilutions. (E) Linearity of the peak area increase in serum was evaluated by testing a serum sample from a patient with an APOE ε3 / ε4 genotype in serial dilutions.
100x 1 49na Sr Apo Tirf Oil Objective, supplied by Nikon, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apoe-/Objectives/bio_rxiv__64898__2026__11__04__764177-203-26-32
Average 99 stars, based on 1 article reviews
100x 1 49na sr apo tirf oil objective - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Nikon na plan apo air objectives
Validation of the ApoE4 and <t>Pan‐ApoE</t> electrophoresis‐based capillary Western blot. (A, B) Western blots of serum (1:400 dilution) and cerebrospinal fluid (CSF) (diluted to 25 mg/L total protein concentration) probed with the anti‐Pan‐ApoE antibody (A) and anti‐ApoE4 antibody (B) from patients with APOE genotypes ε4 / ε4 , ε3 / ε4 , ε2 / ε4 , ε3 / ε3 , ε2 / ε3 , and ε2 / ε2 (each n = 1). For the APOE ε2 / ε2 genotype only serum was available. Bands at 40 kDa in both serum and CSF are observed for every ApoE isoform with the Pan‐ApoE antibody, whereas the anti‐ApoE4 antibody detects 40 kDa bands in both matrices solely in APOE ε4 genotypes. (C) Representative electropherogram illustrating chemiluminescence signal intensity as a function of molecular weight for CSF ( APOE ε3 / ε4 , diluted to 25 mg/L) and serum ( APOE ε3 / ε4 , 1:400 dilution) samples detected with anti‐Pan‐ApoE and anti‐ApoE4 antibodies. (D) Linearity of the Western blot signal (peak area) increase in CSF was assessed using CSF samples from patients with APOE ε3 / ε4 and APOE ε4 / ε4 genotypes in serial dilutions. (E) Linearity of the peak area increase in serum was evaluated by testing a serum sample from a patient with an APOE ε3 / ε4 genotype in serial dilutions.
Na Plan Apo Air Objectives, supplied by Nikon, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apoe-/Objectives/bio_rxiv__64898__2026__10__29__762215-196-26-31
Average 99 stars, based on 1 article reviews
na plan apo air objectives - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Nikon cfi apo tirf 100x oil 1 49 na objective
Validation of the ApoE4 and <t>Pan‐ApoE</t> electrophoresis‐based capillary Western blot. (A, B) Western blots of serum (1:400 dilution) and cerebrospinal fluid (CSF) (diluted to 25 mg/L total protein concentration) probed with the anti‐Pan‐ApoE antibody (A) and anti‐ApoE4 antibody (B) from patients with APOE genotypes ε4 / ε4 , ε3 / ε4 , ε2 / ε4 , ε3 / ε3 , ε2 / ε3 , and ε2 / ε2 (each n = 1). For the APOE ε2 / ε2 genotype only serum was available. Bands at 40 kDa in both serum and CSF are observed for every ApoE isoform with the Pan‐ApoE antibody, whereas the anti‐ApoE4 antibody detects 40 kDa bands in both matrices solely in APOE ε4 genotypes. (C) Representative electropherogram illustrating chemiluminescence signal intensity as a function of molecular weight for CSF ( APOE ε3 / ε4 , diluted to 25 mg/L) and serum ( APOE ε3 / ε4 , 1:400 dilution) samples detected with anti‐Pan‐ApoE and anti‐ApoE4 antibodies. (D) Linearity of the Western blot signal (peak area) increase in CSF was assessed using CSF samples from patients with APOE ε3 / ε4 and APOE ε4 / ε4 genotypes in serial dilutions. (E) Linearity of the peak area increase in serum was evaluated by testing a serum sample from a patient with an APOE ε3 / ε4 genotype in serial dilutions.
Cfi Apo Tirf 100x Oil 1 49 Na Objective, supplied by Nikon, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apoe-/Objectives/bio_rxiv__64898__2026__11__01__763503-172-22-21
Average 99 stars, based on 1 article reviews
cfi apo tirf 100x oil 1 49 na objective - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Carl Zeiss plan apo 63x 1 4 oil objective
Validation of the ApoE4 and <t>Pan‐ApoE</t> electrophoresis‐based capillary Western blot. (A, B) Western blots of serum (1:400 dilution) and cerebrospinal fluid (CSF) (diluted to 25 mg/L total protein concentration) probed with the anti‐Pan‐ApoE antibody (A) and anti‐ApoE4 antibody (B) from patients with APOE genotypes ε4 / ε4 , ε3 / ε4 , ε2 / ε4 , ε3 / ε3 , ε2 / ε3 , and ε2 / ε2 (each n = 1). For the APOE ε2 / ε2 genotype only serum was available. Bands at 40 kDa in both serum and CSF are observed for every ApoE isoform with the Pan‐ApoE antibody, whereas the anti‐ApoE4 antibody detects 40 kDa bands in both matrices solely in APOE ε4 genotypes. (C) Representative electropherogram illustrating chemiluminescence signal intensity as a function of molecular weight for CSF ( APOE ε3 / ε4 , diluted to 25 mg/L) and serum ( APOE ε3 / ε4 , 1:400 dilution) samples detected with anti‐Pan‐ApoE and anti‐ApoE4 antibodies. (D) Linearity of the Western blot signal (peak area) increase in CSF was assessed using CSF samples from patients with APOE ε3 / ε4 and APOE ε4 / ε4 genotypes in serial dilutions. (E) Linearity of the peak area increase in serum was evaluated by testing a serum sample from a patient with an APOE ε3 / ε4 genotype in serial dilutions.
Plan Apo 63x 1 4 Oil Objective, supplied by Carl Zeiss, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apoe-/Objective+Plan-Apochromat+63x%2F1%2E4+Oil+M27/bio_rxiv__64898__2026__10__30__763064-225-11-5
Average 99 stars, based on 1 article reviews
plan apo 63x 1 4 oil objective - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc anti mouse apoe rabbit igg
Validation of the ApoE4 and <t>Pan‐ApoE</t> electrophoresis‐based capillary Western blot. (A, B) Western blots of serum (1:400 dilution) and cerebrospinal fluid (CSF) (diluted to 25 mg/L total protein concentration) probed with the anti‐Pan‐ApoE antibody (A) and anti‐ApoE4 antibody (B) from patients with APOE genotypes ε4 / ε4 , ε3 / ε4 , ε2 / ε4 , ε3 / ε3 , ε2 / ε3 , and ε2 / ε2 (each n = 1). For the APOE ε2 / ε2 genotype only serum was available. Bands at 40 kDa in both serum and CSF are observed for every ApoE isoform with the Pan‐ApoE antibody, whereas the anti‐ApoE4 antibody detects 40 kDa bands in both matrices solely in APOE ε4 genotypes. (C) Representative electropherogram illustrating chemiluminescence signal intensity as a function of molecular weight for CSF ( APOE ε3 / ε4 , diluted to 25 mg/L) and serum ( APOE ε3 / ε4 , 1:400 dilution) samples detected with anti‐Pan‐ApoE and anti‐ApoE4 antibodies. (D) Linearity of the Western blot signal (peak area) increase in CSF was assessed using CSF samples from patients with APOE ε3 / ε4 and APOE ε4 / ε4 genotypes in serial dilutions. (E) Linearity of the peak area increase in serum was evaluated by testing a serum sample from a patient with an APOE ε3 / ε4 genotype in serial dilutions.
Anti Mouse Apoe Rabbit Igg, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apoe-/ApoE+Rabbit+mAb/pm42963010-430-7-13
Average 94 stars, based on 1 article reviews
anti mouse apoe rabbit igg - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

99
Carl Zeiss plan apo 63x objective
Validation of the ApoE4 and <t>Pan‐ApoE</t> electrophoresis‐based capillary Western blot. (A, B) Western blots of serum (1:400 dilution) and cerebrospinal fluid (CSF) (diluted to 25 mg/L total protein concentration) probed with the anti‐Pan‐ApoE antibody (A) and anti‐ApoE4 antibody (B) from patients with APOE genotypes ε4 / ε4 , ε3 / ε4 , ε2 / ε4 , ε3 / ε3 , ε2 / ε3 , and ε2 / ε2 (each n = 1). For the APOE ε2 / ε2 genotype only serum was available. Bands at 40 kDa in both serum and CSF are observed for every ApoE isoform with the Pan‐ApoE antibody, whereas the anti‐ApoE4 antibody detects 40 kDa bands in both matrices solely in APOE ε4 genotypes. (C) Representative electropherogram illustrating chemiluminescence signal intensity as a function of molecular weight for CSF ( APOE ε3 / ε4 , diluted to 25 mg/L) and serum ( APOE ε3 / ε4 , 1:400 dilution) samples detected with anti‐Pan‐ApoE and anti‐ApoE4 antibodies. (D) Linearity of the Western blot signal (peak area) increase in CSF was assessed using CSF samples from patients with APOE ε3 / ε4 and APOE ε4 / ε4 genotypes in serial dilutions. (E) Linearity of the peak area increase in serum was evaluated by testing a serum sample from a patient with an APOE ε3 / ε4 genotype in serial dilutions.
Plan Apo 63x Objective, supplied by Carl Zeiss, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apoe-/Objective+Plan-Apochromat+63x%2F1%2E4+Oil+M27/10__1016_slash_j__heliyon__2026__e45644-122-13-19
Average 99 stars, based on 1 article reviews
plan apo 63x objective - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Nikon plan apo lambda
Validation of the ApoE4 and <t>Pan‐ApoE</t> electrophoresis‐based capillary Western blot. (A, B) Western blots of serum (1:400 dilution) and cerebrospinal fluid (CSF) (diluted to 25 mg/L total protein concentration) probed with the anti‐Pan‐ApoE antibody (A) and anti‐ApoE4 antibody (B) from patients with APOE genotypes ε4 / ε4 , ε3 / ε4 , ε2 / ε4 , ε3 / ε3 , ε2 / ε3 , and ε2 / ε2 (each n = 1). For the APOE ε2 / ε2 genotype only serum was available. Bands at 40 kDa in both serum and CSF are observed for every ApoE isoform with the Pan‐ApoE antibody, whereas the anti‐ApoE4 antibody detects 40 kDa bands in both matrices solely in APOE ε4 genotypes. (C) Representative electropherogram illustrating chemiluminescence signal intensity as a function of molecular weight for CSF ( APOE ε3 / ε4 , diluted to 25 mg/L) and serum ( APOE ε3 / ε4 , 1:400 dilution) samples detected with anti‐Pan‐ApoE and anti‐ApoE4 antibodies. (D) Linearity of the Western blot signal (peak area) increase in CSF was assessed using CSF samples from patients with APOE ε3 / ε4 and APOE ε4 / ε4 genotypes in serial dilutions. (E) Linearity of the peak area increase in serum was evaluated by testing a serum sample from a patient with an APOE ε3 / ε4 genotype in serial dilutions.
Plan Apo Lambda, supplied by Nikon, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apoe-/Objectives/bio_rxiv__64898__2026__10__21__760499-400-5-11
Average 99 stars, based on 1 article reviews
plan apo lambda - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Carl Zeiss numerical aperture na 1 40 plan apo oil objective
Validation of the ApoE4 and <t>Pan‐ApoE</t> electrophoresis‐based capillary Western blot. (A, B) Western blots of serum (1:400 dilution) and cerebrospinal fluid (CSF) (diluted to 25 mg/L total protein concentration) probed with the anti‐Pan‐ApoE antibody (A) and anti‐ApoE4 antibody (B) from patients with APOE genotypes ε4 / ε4 , ε3 / ε4 , ε2 / ε4 , ε3 / ε3 , ε2 / ε3 , and ε2 / ε2 (each n = 1). For the APOE ε2 / ε2 genotype only serum was available. Bands at 40 kDa in both serum and CSF are observed for every ApoE isoform with the Pan‐ApoE antibody, whereas the anti‐ApoE4 antibody detects 40 kDa bands in both matrices solely in APOE ε4 genotypes. (C) Representative electropherogram illustrating chemiluminescence signal intensity as a function of molecular weight for CSF ( APOE ε3 / ε4 , diluted to 25 mg/L) and serum ( APOE ε3 / ε4 , 1:400 dilution) samples detected with anti‐Pan‐ApoE and anti‐ApoE4 antibodies. (D) Linearity of the Western blot signal (peak area) increase in CSF was assessed using CSF samples from patients with APOE ε3 / ε4 and APOE ε4 / ε4 genotypes in serial dilutions. (E) Linearity of the peak area increase in serum was evaluated by testing a serum sample from a patient with an APOE ε3 / ε4 genotype in serial dilutions.
Numerical Aperture Na 1 40 Plan Apo Oil Objective, supplied by Carl Zeiss, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apoe-/Objective+Plan-Apochromat+63x%2F1%2E4+Oil+M27/pmc13693662-214-6-15
Average 99 stars, based on 1 article reviews
numerical aperture na 1 40 plan apo oil objective - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

Image Search Results


Validation of the ApoE4 and Pan‐ApoE electrophoresis‐based capillary Western blot. (A, B) Western blots of serum (1:400 dilution) and cerebrospinal fluid (CSF) (diluted to 25 mg/L total protein concentration) probed with the anti‐Pan‐ApoE antibody (A) and anti‐ApoE4 antibody (B) from patients with APOE genotypes ε4 / ε4 , ε3 / ε4 , ε2 / ε4 , ε3 / ε3 , ε2 / ε3 , and ε2 / ε2 (each n = 1). For the APOE ε2 / ε2 genotype only serum was available. Bands at 40 kDa in both serum and CSF are observed for every ApoE isoform with the Pan‐ApoE antibody, whereas the anti‐ApoE4 antibody detects 40 kDa bands in both matrices solely in APOE ε4 genotypes. (C) Representative electropherogram illustrating chemiluminescence signal intensity as a function of molecular weight for CSF ( APOE ε3 / ε4 , diluted to 25 mg/L) and serum ( APOE ε3 / ε4 , 1:400 dilution) samples detected with anti‐Pan‐ApoE and anti‐ApoE4 antibodies. (D) Linearity of the Western blot signal (peak area) increase in CSF was assessed using CSF samples from patients with APOE ε3 / ε4 and APOE ε4 / ε4 genotypes in serial dilutions. (E) Linearity of the peak area increase in serum was evaluated by testing a serum sample from a patient with an APOE ε3 / ε4 genotype in serial dilutions.

Journal: Journal of Neurochemistry

Article Title: Limited Passive Diffusion of Apolipoprotein E Across the Human Blood–CSF Barrier: Evidence From Paired CSF /Serum Quotients

doi: 10.1111/jnc.70585

Figure Lengend Snippet: Validation of the ApoE4 and Pan‐ApoE electrophoresis‐based capillary Western blot. (A, B) Western blots of serum (1:400 dilution) and cerebrospinal fluid (CSF) (diluted to 25 mg/L total protein concentration) probed with the anti‐Pan‐ApoE antibody (A) and anti‐ApoE4 antibody (B) from patients with APOE genotypes ε4 / ε4 , ε3 / ε4 , ε2 / ε4 , ε3 / ε3 , ε2 / ε3 , and ε2 / ε2 (each n = 1). For the APOE ε2 / ε2 genotype only serum was available. Bands at 40 kDa in both serum and CSF are observed for every ApoE isoform with the Pan‐ApoE antibody, whereas the anti‐ApoE4 antibody detects 40 kDa bands in both matrices solely in APOE ε4 genotypes. (C) Representative electropherogram illustrating chemiluminescence signal intensity as a function of molecular weight for CSF ( APOE ε3 / ε4 , diluted to 25 mg/L) and serum ( APOE ε3 / ε4 , 1:400 dilution) samples detected with anti‐Pan‐ApoE and anti‐ApoE4 antibodies. (D) Linearity of the Western blot signal (peak area) increase in CSF was assessed using CSF samples from patients with APOE ε3 / ε4 and APOE ε4 / ε4 genotypes in serial dilutions. (E) Linearity of the peak area increase in serum was evaluated by testing a serum sample from a patient with an APOE ε3 / ε4 genotype in serial dilutions.

Article Snippet: Serum samples from 33 and CSF samples from 31 out of 34 patients were analyzed for ApoE4 and Pan‐ApoE concentrations using the chemiluminescent enzyme immunoassays (CLEIA) Lumipulse G ApoE4 and Pan‐ApoE (no RRID found, cat. no. 81453 and 81449, Fujirebio Europe N.V., Gent, Belgium; Research Use Only) on the Lumipulse G600II (RRID:SCR_023515) platform.

Techniques: Biomarker Discovery, Electrophoresis, Western Blot, Protein Concentration, Molecular Weight, Blood/Plasma/Serum Samples

Association between serum Western blot signal intensity and absolute concentration determined by chemiluminescent enzyme immunoassay of Pan‐ApoE and ApoE4. Plots show data from patients with available Western blot and Lumipulse measurements in serum (A, B) and CSF (C, D) for Pan‐ApoE (serum: n = 33, CSF: n = 31) and ApoE4 (serum: n = 24, CSF: n = 22).

Journal: Journal of Neurochemistry

Article Title: Limited Passive Diffusion of Apolipoprotein E Across the Human Blood–CSF Barrier: Evidence From Paired CSF /Serum Quotients

doi: 10.1111/jnc.70585

Figure Lengend Snippet: Association between serum Western blot signal intensity and absolute concentration determined by chemiluminescent enzyme immunoassay of Pan‐ApoE and ApoE4. Plots show data from patients with available Western blot and Lumipulse measurements in serum (A, B) and CSF (C, D) for Pan‐ApoE (serum: n = 33, CSF: n = 31) and ApoE4 (serum: n = 24, CSF: n = 22).

Article Snippet: Serum samples from 33 and CSF samples from 31 out of 34 patients were analyzed for ApoE4 and Pan‐ApoE concentrations using the chemiluminescent enzyme immunoassays (CLEIA) Lumipulse G ApoE4 and Pan‐ApoE (no RRID found, cat. no. 81453 and 81449, Fujirebio Europe N.V., Gent, Belgium; Research Use Only) on the Lumipulse G600II (RRID:SCR_023515) platform.

Techniques: Western Blot, Concentration Assay, Enzyme Immunoassay

Relationship between CSF/serum quotients of Pan‐ApoE and ApoE4, albumin quotient and hydrodynamic radius. (A) Reibergram of study population ( n = 34 participants): CSF/serum quotient of IgG ( Q IgG ) and albumin ( Q Alb ). (B) CSF/serum quotients of Pan‐ApoE ( Q Pan‐ApoE ) and ApoE4 ( Q ApoE4 ) did not differ between patients with intact and dysfunctional blood‐CSF barrier, as indicated by CSF/serum albumin ratio ( Q Alb ). Q Pan‐ApoE : n = 20 probands with normal Q Alb versus n = 14 with increased Q Alb (Mann–Whitney U = 113, p = 0.3587, FDR‐adjusted p = 0.4239). Q ApoE4 : n = 18 probands with normal Q Alb versus n = 6 with increased Q Alb (Mann‐Whitney U = 42, p = 0.4538, FDR‐adjusted p = 0.4915). Box plots show the median (center line), the interquartile range (box), and the minimum and maximum values (whiskers). Individual data points are shown as crosses. (C) The CSF/serum quotient of Pan‐ApoE ( Q Pan‐ApoE , n = 34 probands) as well as ApoE4 ( Q ApoE4 , n = 24 probands) showed no statistically significant association with blood‐CSF barrier function. The observed mean CSF/serum quotients exceed the values expected from the approximated theoretical ApoE Reiber curve by approximately 20‐fold, which assumes CSF ApoE is solely derived from blood via passive diffusion across the blood‐CSF barrier. This model is based on IgG‐derived parameters reflecting similar hydrodynamic radius, without accounting for potential differences in ApoE isoform and lipidation. Results are shown on a double‐logarithmic scale, as commonly applied in Reiber diagrams, and additionally on a linear scale for linear regression analysis. As the theoretical ApoE Reiber curve is nearly linear within the observed range of Q Alb , a linear regression of the measured Q Pan‐ApoE ( Y = −1.296* X + 143.7, R 2 : 0.0050, p = 0.6905, FDR‐adjusted p = 0.6905) as well as Q ApoE4 ( Y = 5.435* X + 151.2, R 2 : 0.0558, p = 0.2664, FDR‐adjusted p = 0.4232) and Q Alb values was performed. CSF/serum Pan‐ApoE and ApoE4 ratio were not correlated to the blood‐CSF barrier function.

Journal: Journal of Neurochemistry

Article Title: Limited Passive Diffusion of Apolipoprotein E Across the Human Blood–CSF Barrier: Evidence From Paired CSF /Serum Quotients

doi: 10.1111/jnc.70585

Figure Lengend Snippet: Relationship between CSF/serum quotients of Pan‐ApoE and ApoE4, albumin quotient and hydrodynamic radius. (A) Reibergram of study population ( n = 34 participants): CSF/serum quotient of IgG ( Q IgG ) and albumin ( Q Alb ). (B) CSF/serum quotients of Pan‐ApoE ( Q Pan‐ApoE ) and ApoE4 ( Q ApoE4 ) did not differ between patients with intact and dysfunctional blood‐CSF barrier, as indicated by CSF/serum albumin ratio ( Q Alb ). Q Pan‐ApoE : n = 20 probands with normal Q Alb versus n = 14 with increased Q Alb (Mann–Whitney U = 113, p = 0.3587, FDR‐adjusted p = 0.4239). Q ApoE4 : n = 18 probands with normal Q Alb versus n = 6 with increased Q Alb (Mann‐Whitney U = 42, p = 0.4538, FDR‐adjusted p = 0.4915). Box plots show the median (center line), the interquartile range (box), and the minimum and maximum values (whiskers). Individual data points are shown as crosses. (C) The CSF/serum quotient of Pan‐ApoE ( Q Pan‐ApoE , n = 34 probands) as well as ApoE4 ( Q ApoE4 , n = 24 probands) showed no statistically significant association with blood‐CSF barrier function. The observed mean CSF/serum quotients exceed the values expected from the approximated theoretical ApoE Reiber curve by approximately 20‐fold, which assumes CSF ApoE is solely derived from blood via passive diffusion across the blood‐CSF barrier. This model is based on IgG‐derived parameters reflecting similar hydrodynamic radius, without accounting for potential differences in ApoE isoform and lipidation. Results are shown on a double‐logarithmic scale, as commonly applied in Reiber diagrams, and additionally on a linear scale for linear regression analysis. As the theoretical ApoE Reiber curve is nearly linear within the observed range of Q Alb , a linear regression of the measured Q Pan‐ApoE ( Y = −1.296* X + 143.7, R 2 : 0.0050, p = 0.6905, FDR‐adjusted p = 0.6905) as well as Q ApoE4 ( Y = 5.435* X + 151.2, R 2 : 0.0558, p = 0.2664, FDR‐adjusted p = 0.4232) and Q Alb values was performed. CSF/serum Pan‐ApoE and ApoE4 ratio were not correlated to the blood‐CSF barrier function.

Article Snippet: Serum samples from 33 and CSF samples from 31 out of 34 patients were analyzed for ApoE4 and Pan‐ApoE concentrations using the chemiluminescent enzyme immunoassays (CLEIA) Lumipulse G ApoE4 and Pan‐ApoE (no RRID found, cat. no. 81453 and 81449, Fujirebio Europe N.V., Gent, Belgium; Research Use Only) on the Lumipulse G600II (RRID:SCR_023515) platform.

Techniques: MANN-WHITNEY, Derivative Assay, Diffusion-based Assay, Analysis, Standard Curve

Association between CSF and serum measurements of Pan‐ApoE and ApoE4. Spearman correlation analyses were performed between dilution corrected peak area of Pan‐ApoE ( n = 34) (A) and ApoE4 ( n = 24) (B), as measured in cerebrospinal fluid (CSF) and serum by electrophoresis‐based capillary Western blot.

Journal: Journal of Neurochemistry

Article Title: Limited Passive Diffusion of Apolipoprotein E Across the Human Blood–CSF Barrier: Evidence From Paired CSF /Serum Quotients

doi: 10.1111/jnc.70585

Figure Lengend Snippet: Association between CSF and serum measurements of Pan‐ApoE and ApoE4. Spearman correlation analyses were performed between dilution corrected peak area of Pan‐ApoE ( n = 34) (A) and ApoE4 ( n = 24) (B), as measured in cerebrospinal fluid (CSF) and serum by electrophoresis‐based capillary Western blot.

Article Snippet: Serum samples from 33 and CSF samples from 31 out of 34 patients were analyzed for ApoE4 and Pan‐ApoE concentrations using the chemiluminescent enzyme immunoassays (CLEIA) Lumipulse G ApoE4 and Pan‐ApoE (no RRID found, cat. no. 81453 and 81449, Fujirebio Europe N.V., Gent, Belgium; Research Use Only) on the Lumipulse G600II (RRID:SCR_023515) platform.

Techniques: Electrophoresis, Western Blot

Felgenhauer plot of Pan‐ApoE and ApoE4. The Felgenhauer plot illustrates the relationship between the expected CSF/serum quotient ( Y ‐axis) and hydrodynamic radius ( X ‐axis) of a solute (e.g., protein like ApoE) assuming exclusive blood‐derived passive diffusion across the blood‐CSF barrier (red solid line, see Felgenhauer ). The observed mean CSF/serum quotients of Pan‐ApoE ( n = 34) and ApoE4 ( n = 24) are approximately 66–1320‐fold and 96–1910‐fold higher, respectively, than expected from passive diffusion alone.

Journal: Journal of Neurochemistry

Article Title: Limited Passive Diffusion of Apolipoprotein E Across the Human Blood–CSF Barrier: Evidence From Paired CSF /Serum Quotients

doi: 10.1111/jnc.70585

Figure Lengend Snippet: Felgenhauer plot of Pan‐ApoE and ApoE4. The Felgenhauer plot illustrates the relationship between the expected CSF/serum quotient ( Y ‐axis) and hydrodynamic radius ( X ‐axis) of a solute (e.g., protein like ApoE) assuming exclusive blood‐derived passive diffusion across the blood‐CSF barrier (red solid line, see Felgenhauer ). The observed mean CSF/serum quotients of Pan‐ApoE ( n = 34) and ApoE4 ( n = 24) are approximately 66–1320‐fold and 96–1910‐fold higher, respectively, than expected from passive diffusion alone.

Article Snippet: Serum samples from 33 and CSF samples from 31 out of 34 patients were analyzed for ApoE4 and Pan‐ApoE concentrations using the chemiluminescent enzyme immunoassays (CLEIA) Lumipulse G ApoE4 and Pan‐ApoE (no RRID found, cat. no. 81453 and 81449, Fujirebio Europe N.V., Gent, Belgium; Research Use Only) on the Lumipulse G600II (RRID:SCR_023515) platform.

Techniques: Derivative Assay, Diffusion-based Assay

Validation of the ApoE4 and Pan‐ApoE electrophoresis‐based capillary Western blot. (A, B) Western blots of serum (1:400 dilution) and cerebrospinal fluid (CSF) (diluted to 25 mg/L total protein concentration) probed with the anti‐Pan‐ApoE antibody (A) and anti‐ApoE4 antibody (B) from patients with APOE genotypes ε4 / ε4 , ε3 / ε4 , ε2 / ε4 , ε3 / ε3 , ε2 / ε3 , and ε2 / ε2 (each n = 1). For the APOE ε2 / ε2 genotype only serum was available. Bands at 40 kDa in both serum and CSF are observed for every ApoE isoform with the Pan‐ApoE antibody, whereas the anti‐ApoE4 antibody detects 40 kDa bands in both matrices solely in APOE ε4 genotypes. (C) Representative electropherogram illustrating chemiluminescence signal intensity as a function of molecular weight for CSF ( APOE ε3 / ε4 , diluted to 25 mg/L) and serum ( APOE ε3 / ε4 , 1:400 dilution) samples detected with anti‐Pan‐ApoE and anti‐ApoE4 antibodies. (D) Linearity of the Western blot signal (peak area) increase in CSF was assessed using CSF samples from patients with APOE ε3 / ε4 and APOE ε4 / ε4 genotypes in serial dilutions. (E) Linearity of the peak area increase in serum was evaluated by testing a serum sample from a patient with an APOE ε3 / ε4 genotype in serial dilutions.

Journal: Journal of Neurochemistry

Article Title: Limited Passive Diffusion of Apolipoprotein E Across the Human Blood–CSF Barrier: Evidence From Paired CSF /Serum Quotients

doi: 10.1111/jnc.70585

Figure Lengend Snippet: Validation of the ApoE4 and Pan‐ApoE electrophoresis‐based capillary Western blot. (A, B) Western blots of serum (1:400 dilution) and cerebrospinal fluid (CSF) (diluted to 25 mg/L total protein concentration) probed with the anti‐Pan‐ApoE antibody (A) and anti‐ApoE4 antibody (B) from patients with APOE genotypes ε4 / ε4 , ε3 / ε4 , ε2 / ε4 , ε3 / ε3 , ε2 / ε3 , and ε2 / ε2 (each n = 1). For the APOE ε2 / ε2 genotype only serum was available. Bands at 40 kDa in both serum and CSF are observed for every ApoE isoform with the Pan‐ApoE antibody, whereas the anti‐ApoE4 antibody detects 40 kDa bands in both matrices solely in APOE ε4 genotypes. (C) Representative electropherogram illustrating chemiluminescence signal intensity as a function of molecular weight for CSF ( APOE ε3 / ε4 , diluted to 25 mg/L) and serum ( APOE ε3 / ε4 , 1:400 dilution) samples detected with anti‐Pan‐ApoE and anti‐ApoE4 antibodies. (D) Linearity of the Western blot signal (peak area) increase in CSF was assessed using CSF samples from patients with APOE ε3 / ε4 and APOE ε4 / ε4 genotypes in serial dilutions. (E) Linearity of the peak area increase in serum was evaluated by testing a serum sample from a patient with an APOE ε3 / ε4 genotype in serial dilutions.

Article Snippet: Because ApoE levels in CSF are approximately 10 times lower than those in serum, quantification of ApoE in CSF using the Lumipulse Pan‐ApoE and ApoE4 assays may be problematic.

Techniques: Biomarker Discovery, Electrophoresis, Western Blot, Protein Concentration, Molecular Weight, Blood/Plasma/Serum Samples

Association between serum Western blot signal intensity and absolute concentration determined by chemiluminescent enzyme immunoassay of Pan‐ApoE and ApoE4. Plots show data from patients with available Western blot and Lumipulse measurements in serum (A, B) and CSF (C, D) for Pan‐ApoE (serum: n = 33, CSF: n = 31) and ApoE4 (serum: n = 24, CSF: n = 22).

Journal: Journal of Neurochemistry

Article Title: Limited Passive Diffusion of Apolipoprotein E Across the Human Blood–CSF Barrier: Evidence From Paired CSF /Serum Quotients

doi: 10.1111/jnc.70585

Figure Lengend Snippet: Association between serum Western blot signal intensity and absolute concentration determined by chemiluminescent enzyme immunoassay of Pan‐ApoE and ApoE4. Plots show data from patients with available Western blot and Lumipulse measurements in serum (A, B) and CSF (C, D) for Pan‐ApoE (serum: n = 33, CSF: n = 31) and ApoE4 (serum: n = 24, CSF: n = 22).

Article Snippet: Because ApoE levels in CSF are approximately 10 times lower than those in serum, quantification of ApoE in CSF using the Lumipulse Pan‐ApoE and ApoE4 assays may be problematic.

Techniques: Western Blot, Concentration Assay, Enzyme Immunoassay

Relationship between CSF/serum quotients of Pan‐ApoE and ApoE4, albumin quotient and hydrodynamic radius. (A) Reibergram of study population ( n = 34 participants): CSF/serum quotient of IgG ( Q IgG ) and albumin ( Q Alb ). (B) CSF/serum quotients of Pan‐ApoE ( Q Pan‐ApoE ) and ApoE4 ( Q ApoE4 ) did not differ between patients with intact and dysfunctional blood‐CSF barrier, as indicated by CSF/serum albumin ratio ( Q Alb ). Q Pan‐ApoE : n = 20 probands with normal Q Alb versus n = 14 with increased Q Alb (Mann–Whitney U = 113, p = 0.3587, FDR‐adjusted p = 0.4239). Q ApoE4 : n = 18 probands with normal Q Alb versus n = 6 with increased Q Alb (Mann‐Whitney U = 42, p = 0.4538, FDR‐adjusted p = 0.4915). Box plots show the median (center line), the interquartile range (box), and the minimum and maximum values (whiskers). Individual data points are shown as crosses. (C) The CSF/serum quotient of Pan‐ApoE ( Q Pan‐ApoE , n = 34 probands) as well as ApoE4 ( Q ApoE4 , n = 24 probands) showed no statistically significant association with blood‐CSF barrier function. The observed mean CSF/serum quotients exceed the values expected from the approximated theoretical ApoE Reiber curve by approximately 20‐fold, which assumes CSF ApoE is solely derived from blood via passive diffusion across the blood‐CSF barrier. This model is based on IgG‐derived parameters reflecting similar hydrodynamic radius, without accounting for potential differences in ApoE isoform and lipidation. Results are shown on a double‐logarithmic scale, as commonly applied in Reiber diagrams, and additionally on a linear scale for linear regression analysis. As the theoretical ApoE Reiber curve is nearly linear within the observed range of Q Alb , a linear regression of the measured Q Pan‐ApoE ( Y = −1.296* X + 143.7, R 2 : 0.0050, p = 0.6905, FDR‐adjusted p = 0.6905) as well as Q ApoE4 ( Y = 5.435* X + 151.2, R 2 : 0.0558, p = 0.2664, FDR‐adjusted p = 0.4232) and Q Alb values was performed. CSF/serum Pan‐ApoE and ApoE4 ratio were not correlated to the blood‐CSF barrier function.

Journal: Journal of Neurochemistry

Article Title: Limited Passive Diffusion of Apolipoprotein E Across the Human Blood–CSF Barrier: Evidence From Paired CSF /Serum Quotients

doi: 10.1111/jnc.70585

Figure Lengend Snippet: Relationship between CSF/serum quotients of Pan‐ApoE and ApoE4, albumin quotient and hydrodynamic radius. (A) Reibergram of study population ( n = 34 participants): CSF/serum quotient of IgG ( Q IgG ) and albumin ( Q Alb ). (B) CSF/serum quotients of Pan‐ApoE ( Q Pan‐ApoE ) and ApoE4 ( Q ApoE4 ) did not differ between patients with intact and dysfunctional blood‐CSF barrier, as indicated by CSF/serum albumin ratio ( Q Alb ). Q Pan‐ApoE : n = 20 probands with normal Q Alb versus n = 14 with increased Q Alb (Mann–Whitney U = 113, p = 0.3587, FDR‐adjusted p = 0.4239). Q ApoE4 : n = 18 probands with normal Q Alb versus n = 6 with increased Q Alb (Mann‐Whitney U = 42, p = 0.4538, FDR‐adjusted p = 0.4915). Box plots show the median (center line), the interquartile range (box), and the minimum and maximum values (whiskers). Individual data points are shown as crosses. (C) The CSF/serum quotient of Pan‐ApoE ( Q Pan‐ApoE , n = 34 probands) as well as ApoE4 ( Q ApoE4 , n = 24 probands) showed no statistically significant association with blood‐CSF barrier function. The observed mean CSF/serum quotients exceed the values expected from the approximated theoretical ApoE Reiber curve by approximately 20‐fold, which assumes CSF ApoE is solely derived from blood via passive diffusion across the blood‐CSF barrier. This model is based on IgG‐derived parameters reflecting similar hydrodynamic radius, without accounting for potential differences in ApoE isoform and lipidation. Results are shown on a double‐logarithmic scale, as commonly applied in Reiber diagrams, and additionally on a linear scale for linear regression analysis. As the theoretical ApoE Reiber curve is nearly linear within the observed range of Q Alb , a linear regression of the measured Q Pan‐ApoE ( Y = −1.296* X + 143.7, R 2 : 0.0050, p = 0.6905, FDR‐adjusted p = 0.6905) as well as Q ApoE4 ( Y = 5.435* X + 151.2, R 2 : 0.0558, p = 0.2664, FDR‐adjusted p = 0.4232) and Q Alb values was performed. CSF/serum Pan‐ApoE and ApoE4 ratio were not correlated to the blood‐CSF barrier function.

Article Snippet: Because ApoE levels in CSF are approximately 10 times lower than those in serum, quantification of ApoE in CSF using the Lumipulse Pan‐ApoE and ApoE4 assays may be problematic.

Techniques: MANN-WHITNEY, Derivative Assay, Diffusion-based Assay, Analysis, Standard Curve

Association between CSF and serum measurements of Pan‐ApoE and ApoE4. Spearman correlation analyses were performed between dilution corrected peak area of Pan‐ApoE ( n = 34) (A) and ApoE4 ( n = 24) (B), as measured in cerebrospinal fluid (CSF) and serum by electrophoresis‐based capillary Western blot.

Journal: Journal of Neurochemistry

Article Title: Limited Passive Diffusion of Apolipoprotein E Across the Human Blood–CSF Barrier: Evidence From Paired CSF /Serum Quotients

doi: 10.1111/jnc.70585

Figure Lengend Snippet: Association between CSF and serum measurements of Pan‐ApoE and ApoE4. Spearman correlation analyses were performed between dilution corrected peak area of Pan‐ApoE ( n = 34) (A) and ApoE4 ( n = 24) (B), as measured in cerebrospinal fluid (CSF) and serum by electrophoresis‐based capillary Western blot.

Article Snippet: Because ApoE levels in CSF are approximately 10 times lower than those in serum, quantification of ApoE in CSF using the Lumipulse Pan‐ApoE and ApoE4 assays may be problematic.

Techniques: Electrophoresis, Western Blot

Felgenhauer plot of Pan‐ApoE and ApoE4. The Felgenhauer plot illustrates the relationship between the expected CSF/serum quotient ( Y ‐axis) and hydrodynamic radius ( X ‐axis) of a solute (e.g., protein like ApoE) assuming exclusive blood‐derived passive diffusion across the blood‐CSF barrier (red solid line, see Felgenhauer ). The observed mean CSF/serum quotients of Pan‐ApoE ( n = 34) and ApoE4 ( n = 24) are approximately 66–1320‐fold and 96–1910‐fold higher, respectively, than expected from passive diffusion alone.

Journal: Journal of Neurochemistry

Article Title: Limited Passive Diffusion of Apolipoprotein E Across the Human Blood–CSF Barrier: Evidence From Paired CSF /Serum Quotients

doi: 10.1111/jnc.70585

Figure Lengend Snippet: Felgenhauer plot of Pan‐ApoE and ApoE4. The Felgenhauer plot illustrates the relationship between the expected CSF/serum quotient ( Y ‐axis) and hydrodynamic radius ( X ‐axis) of a solute (e.g., protein like ApoE) assuming exclusive blood‐derived passive diffusion across the blood‐CSF barrier (red solid line, see Felgenhauer ). The observed mean CSF/serum quotients of Pan‐ApoE ( n = 34) and ApoE4 ( n = 24) are approximately 66–1320‐fold and 96–1910‐fold higher, respectively, than expected from passive diffusion alone.

Article Snippet: Because ApoE levels in CSF are approximately 10 times lower than those in serum, quantification of ApoE in CSF using the Lumipulse Pan‐ApoE and ApoE4 assays may be problematic.

Techniques: Derivative Assay, Diffusion-based Assay